ECB Rate Path May Deepen Stagflation Risks Berenberg Economist Warns
Estate Transparency Crisis Sister Refuses to Explain Control of Mothers Assets
Huawei Unveils New Chip Design Approach Amid US Restrictions Intensifying Tech Rivalry
HELOC Rates Remain Low but Fed Rate Hike Expectations Could Shift the Landscape
Telecom CEO Warns Europe Faces Strategic Vulnerability to US Satellite and AI Dominance
Intel Pushes PC Makers Toward 18A Chips as AI Demand Surges Margin Boost Potential
RELX Q2 2025 Earnings Narrow EPS Beat with Slight Stock Decline
PLX Q1 2026 Earnings Massive EPS Surprise Drives Stock Higher
Ascent Solar Technologies Inc ASTI Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Elusive
Sunrun RUN Q1 2026 Earnings Solar Leader Posts Record EPS Surprise Shares Rally
SAY Q1 2026 Earnings Significant Earnings Miss with Negative EPS
LyondellBasell LYB Q1 2026 Earnings Surprise EPS Beat Fails to Lift Shares as Market Focuses on Demand Concerns
FGI Industries Surges Over 7 as Positive Momentum Builds
AEye Inc Warrant LIDRW Surges 10 but Holds at Key Support Analysis of Recent Activity
Tyson Foods TSN Holds Steady Near Support Despite Modest Uptick
MEDIROM Healthcare Technologies MRM Surges 30 Key Levels and Potential Drivers
OXSQH Edges Higher as Bond Investors Assess Rate Path and Credit Stability
US Charges Google Engineer with Insider Trading on Polymarket Prediction Platform
Amicus Therapeutics Q4 2025 Earnings EPS Misses Expectations by a Wide Margin
Incannex Healthcare IXHL Slips 455 as Biotech Selling Pressure Persists
FFWM Q4 2025 Earnings EPS Significantly Misses Estimates Stock Rises 243
PDEX Q1 2026 Earnings EPS Surges 8975 Above Estimates Amid Stock Decline
AVB Q1 2026 Earnings EPS Surpasses Estimates by 81 Amid Stable Multifamily Demand
BMA Q4 2025 Earnings Strong EPS Beat Amidst Mixed Market Reaction
SPCE Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Surge
NTZ Q4 2011 Earnings Significant EPS Miss as Company Reports WiderthanExpected Loss
PYPD Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances